NCT05489770View on ClinicalTrials.gov

BERRY- a Study of Sambucol ® in the Treatment, and Reduction of Symptoms in Participants With Coronavirus 19

NACompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions

COVID-19

Interventions

DIETARY_SUPPLEMENT

Sambucol® Black Elderberry Original (Sambucus nigra) Liquid

Sambucol® Black Elderberry Original (Sambucus nigra) Liquid has been used as a supplement since 1991 with no reports of adverse effects received by the Manufacturer.

DIETARY_SUPPLEMENT

Placebo for Sambucol® Black Elderberry Original (Sambucus nigra)

Placebo for Sambucol® Black Elderberry Original (Sambucus nigra) Liquid Constituents: 70% (w/w) of glucose syrup, Flavouring agent: Elderberry Blossom

Trial Locations (1)

CT1 3NG

East Kent Hospitals University NHS Foundation trust, Canterbury

All Listed Sponsors

lead

East Kent Hospitals University NHS Foundation Trust

OTHER_GOV

NCT05489770 - BERRY- a Study of Sambucol ® in the Treatment, and Reduction of Symptoms in Participants With Coronavirus 19 | Biotech Hunter | Biotech Hunter